Inflammatory Bowel Disease Is a Risk Factor for Recurrent Venous Thromboembolism

被引:208
作者
Novacek, Gottfried [1 ]
Weltermann, Ansgar [2 ]
Sobala, Anna
Tilg, Herbert [3 ]
Petritsch, Wolfgang [4 ]
Reinisch, Walter
Mayer, Andreas [5 ]
Haas, Thomas [6 ]
Kaser, Arthur [7 ]
Feichtenschlager, Thomas [8 ]
Fuchssteiner, Harry [9 ]
Knoflach, Peter [11 ]
Vogelsang, Harald
Miehsler, Wolfgang
Platzer, Reingard [10 ]
Tillinger, Wolfgang [12 ]
Jaritz, Bernhard [13 ]
Schmid, Alfons [14 ]
Blaha, Benedikt [15 ]
Dejaco, Clemens
Eichinger, Sabine [16 ]
机构
[1] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, A-1090 Vienna, Austria
[2] Elisabethinen Hosp Linz, Dept Internal Med 1, Linz, Austria
[3] Acad Teaching Hosp Hall Tirol, Dept Med, Hall In Tirol, Austria
[4] Med Univ Graz, Dept Internal Med, Graz, Austria
[5] Gen Hosp St Polten, Dept Internal Med, St Polten, Austria
[6] Paracelsus Private Med Univ, Dept Internal Med 1, Salzburg, Austria
[7] Innsbruck Med Univ, Dept Internal Med 2, Innsbruck, Austria
[8] Hosp Rudolfstiftung, Dept Internal Med 4, Vienna, Austria
[9] Elisabethinen Hosp Linz, Dept Internal Med 4, Linz, Austria
[10] Wiener Neustadt Gen Hosp, Dept Internal Med 1, Wiener Neustadt, Austria
[11] Klinikum Wels, Dept Gastroenterol, Wels, Austria
[12] Gen Hosp Hietzing, Dept Internal Med 1, Vienna, Austria
[13] Landesklinikum Mistelbach Ganserndorf, Dept Internal Med 2, Mistelbach, Austria
[14] Danube Hosp, Dept Internal Med 2, Vienna, Austria
[15] Wilheminenspital Stadt Wien, Dept Internal Med 4, Vienna, Austria
[16] Med Univ Vienna, Dept Internal Med 1, A-1090 Vienna, Austria
关键词
Crohn's Disease; Ulcerative Colitis; Active Disease; Provoked Thrombosis; DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; ULCERATIVE-COLITIS; PROSPECTIVE-COHORT; END-POINTS; THERAPY; ANTICOAGULATION; METAANALYSIS; COAGULATION; MORTALITY;
D O I
10.1053/j.gastro.2010.05.026
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Patients with inflammatory bowel disease (IBD) are at increased risk of a first venous thromboembolism (VTE), yet their risk of recurrent VTE is unknown. We performed a cohort study to determine the risk for recurrent VTE among patients with IBD compared with subjects without IBD. METHODS: We assessed 2811 patients with IBD for a history of VTE, recruited from outpatient clinics at 14 referral centers (June 2006-December 2008). Patients with VTE before a diagnosis of IBD or those not confirmed to have VTE, cancer, or a VTE other than deep vein thrombosis or pulmonary embolism, were excluded. Recurrence rates were compared with 1255 prospectively followed patients without IBD that had a first unprovoked VTE (not triggered by trauma, surgery, or pregnancy). The primary end point was symptomatic, objectively confirmed, recurrent VTE after discontinuation of anticoagulation therapy after a first VTE. RESULTS: Overall, of 116 IBD patients who had a history of first VTE, 86 were unprovoked. The probability of recurrence 5 years after discontinuation of anticoagulation therapy was higher among patients with IBD than patients without IBD (33.4%; 95% confidence interval [CI]: 21.8 -45.0 vs 21.7%; 95% CI: 18.8-24.6; P = .01). After adjustment for potential confounders, IBD was an independent risk factor of recurrence (hazard ratio = 2.5; 95% CI: 1.4-4.2; P = .001). CONCLUSIONS: Patients with IBD are at an increased risk of recurrent VTE compared to patients without IBD.
引用
收藏
页码:779 / U114
页数:10
相关论文
共 50 条
[1]   Venous thromboembolism and cancer [J].
Baron, JA ;
Gridley, G ;
Weiderpass, E ;
Nyrén, O ;
Linet, M .
LANCET, 1998, 351 (9109) :1077-1080
[2]  
Bernstein CN, 2001, THROMB HAEMOSTASIS, V85, P430
[3]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[4]  
BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185
[5]   Deep vein thrombosis and pulmonary embolism in two cohorts: The longitudinal investigation of thromboembolism etiology [J].
Cushman, M ;
Tsai, AW ;
White, RH ;
Heckbert, SR ;
Rosamond, WD ;
Enright, P ;
Folsom, AR .
AMERICAN JOURNAL OF MEDICINE, 2004, 117 (01) :19-25
[6]   A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis [J].
D'Haens, Geert ;
Sandborn, William J. ;
Feagan, Brian G. ;
Geboes, Karel ;
Hanauer, Stephen B. ;
Irvine, E. Jan ;
Lemann, Marc ;
Marteau, Philippe ;
Rutgeerts, Paul ;
Scholmerich, Jurgen ;
Sutherland, Lloyd R. .
GASTROENTEROLOGY, 2007, 132 (02) :763-786
[7]   Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients [J].
Danese, S ;
Katz, JA ;
Saibeni, S ;
Papa, A ;
Gasbarrini, A ;
Vecchi, M ;
Fiocchi, C .
GUT, 2003, 52 (10) :1435-1441
[8]   Inflammation and coagulation in inflammatory bowel disease: The clot thickens [J].
Danese, Silvio ;
Papa, Alfredo ;
Saibeni, Simone ;
Repici, Alessandro ;
Malesci, Alberto ;
Vecchi, Maurizio .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (01) :174-186
[9]   The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism [J].
Douketis, James D. ;
Gu, Chu Shu ;
Schulman, Sam ;
Ghirarduzzi, Angelo ;
Pengo, Vittorio ;
Prandoni, Paolo .
ANNALS OF INTERNAL MEDICINE, 2007, 147 (11) :766-U36
[10]  
EDWARDS FC, 1964, GUT, V5, P1